BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Raven Biotechnologies, Inc. 

1140 Veterans Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-624-2600 Fax: 650-553-9169


SEARCH JOBS



Segment
Drug Discovery

Collaborations

ImmunoGen, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Medarex, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.





 Company News
VaxGen, Inc. (VXGN) Receives Repayment in Full of Bridge Loan to Raven Biotechnologies, Inc. 7/18/2008 10:45:29 AM    More...
MacroGenics, Inc. (JOBS) Acquires Raven Biotechnologies, Inc. 7/17/2008 6:28:50 AM    More...
Raven Biotechnologies, Inc. Announces Collaboration With Monogram Biosciences (MGRM) to Advance Diagnostic Cancer Technologies 4/8/2008 6:53:21 AM    More...
Raven Biotechnologies, Inc. and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies 4/4/2008 7:08:30 AM    More...
VaxGen, Inc. (VXGN) and Raven Biotechnologies, Inc. Terminate Merger Agreement 3/28/2008 6:42:38 AM    More...
VaxGen, Inc. (VXGN) Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven Biotechnologies, Inc. 3/21/2008 7:34:05 AM    More...
MedCap Corp. (MPCPF.PK) Urges Vote Against Proposed VaxGen, Inc. (VXGN) Merger With Raven Biotechnologies, Inc. 3/20/2008 9:10:06 AM    More...
Raven Biotechnologies, Inc. Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 3/13/2008 6:38:15 AM    More...
Raven Biotechnologies, Inc. Advances RAV18 Through Agreement With CMC ICOS Biologics 3/12/2008 8:59:01 AM    More...
Raven Biotechnologies, Inc. Announces RAV12 Phase 1/2a Study Results To Be Presented at American Society of Clinical Oncology 3/11/2008 10:49:27 AM    More...
12345

//-->